Mu et al. found that KD intervention could mitigate pulmonary fibrosis in vivo via upregulating the expression of LC3 II/LC3 I and Beclin1 and downregulating the expression of P62 [42]. Here, SQSTM1 is linked to pulmonary fibrosis.